Letter to the editor-The new FIGO staging system for endometrial cancer: Is the paradigm shift clinically feasible?
Int J Gynaecol Obstet
.
2024 Jan;164(1):364-365.
doi: 10.1002/ijgo.15265.
Epub 2023 Dec 6.
Authors
Ilaria Betella
1
,
Luigi Antonio De Vitis
1
2
,
Carmelo Calidona
3
,
Francesco Multinu
1
,
Nicoletta Colombo
1
4
Affiliations
1
Department of Gynecology, European Institute of Oncology, IEO, IRCCS, Milan, Italy.
2
Division of Gynecologic Surgery, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota, USA.
3
Department of Obstetrics and Gynecology, AOUI Verona, University of Verona, Verona, Italy.
4
Faculty of Medicine and Surgery, University of Milan Bicocca, Milan, Italy.
PMID:
38055223
DOI:
10.1002/ijgo.15265
No abstract available
Publication types
Letter
MeSH terms
Endometrial Neoplasms* / pathology
Female
Humans
Neoplasm Staging
Prognosis